Without a carve-out for tariff exceptions for pharmaceuticals, prices will skyrocket for US patients, experts warn.

Eli Lilly said it plans to submit the pill to the Food and Drug Administration for approval as a weight loss medication this ...

Biosimilars are proving to be a game-changing solution in the fight against inflammatory bowel disease (IBD), offering a cost ...

While much of the conversation around the Trump administration’s potential pharmaceutical import tariffs has leaned heavily ...

A new study lays out a scientific framework for holding individual fossil fuel companies liable for the costs of climate change by tracing specific damages back to their emissions. The researchers use ...

California Governor Gavin Newsom announced Monday that the price of this drug, better known as the brand name of Narcan, is ...

Missouri Attorney General Andrew Bailey has joined a bipartisan coalition of 39 attorneys general in urging Congress to take ...

Drought-fueled wildfires in Southern California, a devastating hurricane in the southern Appalachian Mountains, and ...

Key takeaways State attorneys general argue that PBMs owning pharmacies creates conflicts of interest and inflates drug ...

Bristol Myers Squibb’s new treatment for schizophrenia didn’t provide additional benefits to patients when given on top of ...

Janelle Zeihen worried she'd have to file for bankruptcy after learning she owed $250,000 for her Crohn's disease treatment.

Oncology experts discuss de-escalation strategies that can reduce toxicity, save a billion in healthcare costs, and make lung ...